Vidalista 60 mg contains 60 mg of tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor. Although tadalafil is approved to treat certain forms of pulmonary arterial hypertension (PAH), Vidalista 60 mg is not intended or approved for that purpose. For PAH, tadalafil is prescribed under specific brand names and dosing regimens that are different from those used for erectile dysfunction. The usual dose for adults with PAH is 40 mg once daily (typically taken as two 20 mg tablets), but the appropriate dose depends on the person's condition,Vidalista 60 mg and liver function, and other medications. Vidalista 60 mg is marketed primarily for erectile dysfunction (ED). Using it to self-treat pulmonary hypertension is not recommended, as the higher 60 mg strength has not been established as a standard treatment for PAH and may increase the risk of side effects such as headache, flushing, low blood pressure, dizziness, nasal congestion, and muscle or back pain. People with pulmonary hypertension require careful evaluation to determine the cause of their condition and the most appropriate therapy. Treatment may include tadalafil or other medications, but it should be prescribed and monitored by a healthcare professional experienced in managing PAH. If you have pulmonary hypertension or think you may have it, do not use Vidalista 60 mg without medical advice. A healthcare provider can determine whether tadalafil is appropriate, select the correct formulation and dose, and monitor for potential drug interactions and side effects.